Cargando…
Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa
BACKGROUND: Cervical cancer, one of the most common cancers affecting females in South Africa, commonly requires a cisplatin-based-treatment regimen, which has been associated with ototoxic side effects. However, cisplatin-associated ototoxicity is largely under-reported in South Africa, despite its...
Autores principales: | Paken, Jessica, Govender, Cyril D., Pillay, Mershen, Ayele, Birhanu T., Sewram, Vikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285889/ https://www.ncbi.nlm.nih.gov/pubmed/34271863 http://dx.doi.org/10.1186/s12885-021-08567-0 |
Ejemplares similares
-
Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa
por: Paken, Jessica, et al.
Publicado: (2023) -
Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity
por: Paken, Jessica, et al.
Publicado: (2021) -
Cisplatin-Associated Ototoxicity: A Review for the Health Professional
por: Paken, Jessica, et al.
Publicado: (2016) -
Perspectives and practices of ototoxicity monitoring
por: Paken, Jessica, et al.
Publicado: (2020) -
Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting
por: Paken, Jessica, et al.
Publicado: (2022)